keyword
https://read.qxmd.com/read/38632930/anti-neuraminidase-immunity-in-the-combat-against-influenza
#21
REVIEW
Xiaojian Zhang, Ted M Ross
INTRODUCTION: Anti-neuraminidase (NA) immunity correlates with the protection against influenza virus infection in both human and animal models. The aim of this review is to better understand the mechanism of anti-NA immunity, and also to evaluate the approaches on developing NA-based influenza vaccines or enhancing immune responses against NA for current influenza vaccines. AREAS COVERED: In this review, the structure of influenza neuraminidase, the contribution of anti-NA immunity to protection, as well as the efforts and challenges of targeting the immune responses to NA were discussed...
April 17, 2024: Expert Review of Vaccines
https://read.qxmd.com/read/38632563/db-1310-an-adc-comprised-of-a-novel-anti-her3-antibody-conjugated-to-a-dna-topoisomerase-i-inhibitor-is-highly-effective-for-the-treatment-of-her3-positive-solid-tumors
#22
JOURNAL ARTICLE
Xi Li, Jun Yao, Chen Qu, Lan Luo, Bing Li, Yu Zhang, Zhongyuan Zhu, Yang Qiu, Haiqing Hua
BACKGROUND: HER3 (ErbB3), a member of the human epidermal growth factor receptor family, is frequently overexpressed in various cancers. Multiple HER3-targeting antibodies and antibody-drug conjugates (ADCs) were developed for the solid tumor treatment, however none of HER3-targeting agent has been approved for tumor therapy yet. We developed DB-1310, a HER3 ADC composed of a novel humanized anti-HER3 monoclonal antibody covalently linked to a proprietary DNA topoisomerase I inhibitor payload (P1021), and evaluate the efficacy and safety of DB-1310 in preclinical models...
April 17, 2024: Journal of Translational Medicine
https://read.qxmd.com/read/38631956/identifying-major-histocompatibility-complex-class-ii-dr-molecules-in-bovine-and-swine-peripheral-blood-monocyte-derived-macrophages-using-mab-l243
#23
JOURNAL ARTICLE
Carmen Celis-Giraldo, Diego Ordoñez, Diana Díaz-Arévalo, Michel D Bohórquez, Nieves Ibarrola, Carlos F Suárez, Kewin Rodríguez, Yoelis Yepes, Alexander Rodríguez, Catalina Avendaño, Julio López-Abán, Raúl Manzano-Román, Manuel Alfonso Patarroyo
Major histocompatibility complex class II (MHC-II) molecules are involved in immune responses against pathogens and vaccine candidates' immunogenicity. Immunopeptidomics for identifying cancer and infection-related antigens and epitopes have benefited from advances in immunopurification methods and mass spectrometry analysis. The mouse anti-MHC-II-DR monoclonal antibody L243 (mAb-L243) has been effective in recognising MHC-II-DR in both human and non-human primates. It has also been shown to cross-react with other animal species, although it has not been tested in livestock...
April 16, 2024: Vaccine
https://read.qxmd.com/read/38630712/the-monocyte-cell-surface-is-a-unique-site-of-autoantigen-generation-in-rheumatoid-arthritis
#24
JOURNAL ARTICLE
Mekha A Thomas, Pooja Naik, Hong Wang, Jon T Giles, Alexander A Girgis, Seok-Young Kim, Tory P Johnson, Ashley M Curran, Jonathan D Crawford, Shaghayegh Jahanbani, Clifton O Bingham, William H Robinson, Chan Hyun Na, Erika Darrah
Although anti-citrullinated protein autoantibodies (ACPAs) are a hallmark serological feature of rheumatoid arthritis (RA), the mechanisms and cellular sources behind the generation of the RA citrullinome remain incompletely defined. Peptidylarginine deiminase IV (PAD4), one of the key enzymatic drivers of citrullination in the RA joint, is expressed by granulocytes and monocytes; however, the subcellular localization and contribution of monocyte-derived PAD4 to the generation of citrullinated autoantigens remain underexplored...
April 23, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38629576/virus-like-particles-derived-from-bacteriophage-ms2-as-antigen-scaffolds-and-rna-protective-shells
#25
REVIEW
Antonina Naskalska, Jonathan Gardiner Heddle
The versatile potential of bacteriophage MS2-derived virus-like particles (VLPs) in medical biotechnology has been extensively studied during the last 30 years. Since the first reports showing that MS2 VLPs can be produced at high yield and relatively easily engineered, numerous applications have been proposed. Particular effort has been spent in developing MS2 VLPs as protective capsules and delivery platforms for diverse molecules, such as chemical compounds, proteins and nucleic acids. Among these, two are particularly noteworthy: as scaffolds displaying heterologous epitopes for vaccine development and as capsids for encapsulation of foreign RNA...
April 17, 2024: Nanomedicine
https://read.qxmd.com/read/38629315/molecular-characterization-of-the-allergenic-arginine-kinase-from-the-edible-insect-hermetia-illucens-black-soldier-fly
#26
JOURNAL ARTICLE
Danila Delfino, Barbara Prandi, Luisa Calcinai, Erminia Ridolo, Luca Dellafiora, Lorenzo Pedroni, Francesca Nicoletta, Davide Cavazzini, Tullia Tedeschi, Claudia Folli
SCOPE: Arginine kinase (AK) is an important enzyme for energy metabolism of invertebrate cells by participating in the maintenance of constant levels of ATP. However, AK is also recognized as a major allergen in insects and crustaceans capable of cross-reactivity with sera of patients sensitized to orthologous proteins. In the perspective of introducing insects or their derivatives in the human diet in Western world, it is of primary importance to evaluate possible risks for allergic consumers...
April 17, 2024: Molecular Nutrition & Food Research
https://read.qxmd.com/read/38629077/experimental-trials-of-predicted-cd4-and-cd8-t-cell-epitopes-of-respiratory-syncytial-virus
#27
JOURNAL ARTICLE
Syeda Tahira Qousain Naqvi, Syed Aun Muhammad, Jinlei Guo, Sidra Zafar, Amjad Ali, Larry J Anderson, Christina A Rostad, Baogang Bai
BACKGROUND: Respiratory syncytial virus (RSV) is the most common cause of viral lower respiratory tract infections (LRTIs) in young children around the world and an important cause of LRTI in the elderly. The available treatments and FDA-approved vaccines for RSV only lessen the severity of the infection and are recommended for infants and elderly people. METHODS: We focused on developing a broad-spectrum vaccine that activates the immune system to directly combat RSV...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38628595/the-role-of-the-pin1-cis-p-tau-axis-in-the-development-and-treatment-of-vascular-contribution-to-cognitive-impairment-and-dementia-and-preeclampsia
#28
REVIEW
Chenxi Qiu, Zhixiong Li, David A Leigh, Bingbing Duan, Joseph E Stucky, Nami Kim, George Xie, Kun Ping Lu, Xiao Zhen Zhou
Tauopathies are neurodegenerative diseases characterized by deposits of abnormal Tau protein in the brain. Conventional tauopathies are often defined by a limited number of Tau epitopes, notably neurofibrillary tangles, but emerging evidence suggests structural heterogeneity among tauopathies. The prolyl isomerase Pin1 isomerizes cis P-tau to inhibit the development of oligomers, tangles and neurodegeneration in multiple neurodegenerative diseases such as Alzheimer's disease, traumatic brain injury, vascular contribution to cognitive impairment and dementia (VCID) and preeclampsia (PE)...
2024: Frontiers in Cell and Developmental Biology
https://read.qxmd.com/read/38628551/a-novel-approach-to-designing-viral-precision-vaccines-applied-to-sars-cov-2
#29
JOURNAL ARTICLE
Khaled Trabelsi, Noureddin Ben Khalaf, Ahmed R Ramadan, Amany Elsharkawy, Dana Ashoor, Sadok Chlif, Thouraya Boussoffara, Melika Ben-Ahmed, Mukesh Kumar, M-Dahmani Fathallah
Efficient precision vaccines against several highly pathogenic zoonotic viruses are currently lacking. Proteolytic activation is instrumental for a number of these viruses to gain host-cell entry and develop infectivity. For SARS-CoV-2, this process is enhanced by the insertion of a furin cleavage site at the junction of the spike protein S1/S2 subunits upstream of the metalloprotease TMPRSS2 common proteolytic site. Here, we describe a new approach based on specific epitopes selection from the region involved in proteolytic activation and infectivity for the engineering of precision candidate vaccinating antigens...
2024: Frontiers in Cellular and Infection Microbiology
https://read.qxmd.com/read/38627681/efficacy-and-safety-of-bispecific-antibodies-vs-immune-checkpoint-blockade-combination-therapy-in-cancer-a-real-world-comparison
#30
REVIEW
Linyan Cheng, Lujun Chen, Yuan Shi, Weiying Gu, Weidong Ding, Xiao Zheng, Yan Liu, Jingting Jiang, Zhuojun Zheng
Emerging tumor immunotherapy methods encompass bispecific antibodies (BSABs), immune checkpoint inhibitors (ICIs), and adoptive cell immunotherapy. BSABs belong to the antibody family that can specifically recognize two different antigens or epitopes on the same antigen. These antibodies demonstrate superior clinical efficacy than monoclonal antibodies, indicating their role as a promising tumor immunotherapy option. Immune checkpoints are also important in tumor immunotherapy. Programmed cell death protein-1 (PD-1) is a widely acknowledged immune checkpoint target with effective anti-tumor activity...
April 16, 2024: Molecular Cancer
https://read.qxmd.com/read/38627373/the-physiological-interactome-of-tcr-like-antibody-therapeutics-in-human-tissues
#31
JOURNAL ARTICLE
Estelle Marrer-Berger, Annalisa Nicastri, Angelique Augustin, Vesna Kramar, Hanqing Liao, Lydia Jasmin Hanisch, Alejandro Carpy, Tina Weinzierl, Evelyne Durr, Nathalie Schaub, Ramona Nudischer, Daniela Ortiz-Franyuti, Ekaterina Breous-Nystrom, Janick Stucki, Nina Hobi, Giulia Raggi, Lauriane Cabon, Emmanuelle Lezan, Pablo Umaña, Isaac Woodhouse, Alexander Bujotzek, Christian Klein, Nicola Ternette
Selective binding of TCR-like antibodies that target a single tumour-specific peptide antigen presented by human leukocyte antigens (HLA) is the absolute prerequisite for their therapeutic suitability and patient safety. To date, selectivity assessment has been limited to peptide library screening and predictive modeling. We developed an experimental platform to de novo identify interactomes of TCR-like antibodies directly in human tissues using mass spectrometry. As proof of concept, we confirm the target epitope of a MAGE-A4-specific TCR-like antibody...
April 16, 2024: Nature Communications
https://read.qxmd.com/read/38626292/bcl2a1-neoepitopes-elicited-cytotoxic-t-lymphocytes-are-a-promising-individualized-immunotherapy-of-pancreatic-cancer
#32
JOURNAL ARTICLE
Shengzhe Lin, Jingwen Hong, Suxin Wu, Chenlu Zhu, Fang Liu, Wansong Lin, Xinran Cai, Yunbin Ye, Yanling Chen
Conventional treatments have shown a limited efficacy for pancreatic cancer, and immunotherapy is an emerging option for treatment of this highly fatal malignancy. Neoantigen is critical to improving the efficacy of tumor-specific immunotherapy. The cancer and peripheral blood specimens from human leukocyte antigen (HLA)-A0201 positive pancreatic cancer patient were subjected to next-generation sequencing and bioinformatics analyses were performed to screen high-affinity and highly stable neoepitopes. The activation of cytotoxic T lymphocytes (CTLs) by the mutBCL2A111-20 neoepitope targeting B-cell lymphoma 2-related protein A1 (BCL2A1) mutant epitope was investigated, and the cytotoxicity of mutBCL2A111-20 neoepitope-specific CTLs to pancreatic cancer cells was evaluated...
April 16, 2024: Journal of Leukocyte Biology
https://read.qxmd.com/read/38624232/epitopes-of-an-antibody-that-neutralizes-a-wide-range-of-sars-cov-2-variants-in-a-conserved-subdomain-1-of-the-spike-protein
#33
JOURNAL ARTICLE
Hanako Ishimaru, Mitsuhiro Nishimura, Hideki Shigematsu, Maria Istiqomah Marini, Natsumi Hasegawa, Rei Takamiya, Sachiyo Iwata, Yasuko Mori
The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has continued, enabling the virus to escape from host immunity by changing its spike antigen, while biased toward the receptor-binding domain and N-terminal domain. Here, we isolated a novel pan-SARS-CoV-2 neutralizing antibody (which we named MO11) for even the recent dominators XBB.1.16 and EG.5.1, from a convalescent patient who had received three doses of an original mRNA COVID-19 vaccination. A cryo-electron microscopy analysis of the spike-MO11 complex at 2...
April 16, 2024: Journal of Virology
https://read.qxmd.com/read/38624064/walking-a-thin-line-between-fixation-and-epitope-binding-characterization-of-antigen-retrieval-methods-suitable-for-eosinophil-and-hsv-2-staining-in-formalin-fixed-female-reproductive-tissue
#34
JOURNAL ARTICLE
Lisa Marie Wadephul, Kathrin Arndts, Gnatoulma Katawa, Eva Dietlmeier, William Horsnell, Achim Hoerauf, Manuel Ritter
Antibody-based fluorescence analysis of female reproductive tissues in research of sexually transmitted diseases allows for an in-depth understanding of protein localization, interactions, and pathogenesis. However, in many cases, cryosectioning is not compatible with biosafety regulations; at all times, exposure of lab personnel and the public to potentially harmful pathogens from biological infectious material must be avoided; thus, formaldehyde fixation is essential. Due to formaldehyde's cross-linking properties, protein detection with antibodies can be impeded...
April 16, 2024: European Journal of Histochemistry: EJH
https://read.qxmd.com/read/38623037/supramolecular-peptide-self-assemblies-facilitate-oral-immunization
#35
JOURNAL ARTICLE
Elizabeth J Curvino, Mia E Woodruff, Emily F Roe, Helena Freire Haddad, Pablo Cordero Alvarado, Joel H Collier
Oral immunization is a promising strategy for preventing and treating gastrointestinal (GI) infections and diseases, as it allows for direct access to the disease site. To elicit immune responses within the GI tract, however, there are many obstacles that oral vaccines must surmount, including proteolytic degradation and thick mucus barriers. Here, we employed a modular self-assembling peptide nanofiber platform to facilitate oral immunization against both peptide and small molecule epitopes. Synthesizing nanofibers with d-amino acids rendered them resistant to proteases in vitro, whereas l-amino acid nanofibers were rapidly degraded...
April 16, 2024: ACS Biomaterials Science & Engineering
https://read.qxmd.com/read/38621704/the-diagnostic-difficulties-of-juvenile-vulvar-pemphigoid
#36
Sophie Gart, Ritu Swali, Erica B Lee, Nicole Harter
Mucous membrane pemphigoid is a rare autoimmune disease affecting mucosal surfaces. Pediatric cases are exceptionally rare, one subtype being vulvar pemphigoid. Juvenile vulvar pemphigoid can be challenging to diagnose due to its rarity and subtle initial symptoms. We present a case of an 8-year-old girl successfully diagnosed early in the disease course via histopathology, and immunofluorescence. Detecting MMP can be complex due to variations in epitope binding typically not included in commercial ELISA assays, necessitating comprehensive workup...
April 15, 2024: Pediatric Dermatology
https://read.qxmd.com/read/38621693/thyroglobulin-antibodies-and-tumor-epitope-specific-cellular-immunity-in-papillary-thyroid-cancer
#37
JOURNAL ARTICLE
Stephanie Allelein, Margret Ehlers, Taina Thoma, Katalin Mattes-György, Christina Antke, Eduards Mamlins, Mareike Muchalla, Frederik Giesel, Matthias Schott
Papillary thyroid carcinoma (PTC) is characterized by T cell infiltration and frequently by the presence of anti-thyroglobulin antibodies (TgAbs). The role of cellular immunity and of TbAbs in this context is a matter of debate. The aim of our study was to correlate the presence of TgAbs, tumor epitope-specific T cells and the clinical outcome of PTC patients. We studied n=183 consecutive patients with a diagnosis of PTC which were treated with total thyroidectomy plus 131 I ablation. During a follow-up of in mean 97 months, most of the PTC patients had no signs of tumor relapse (n=157 patients)...
April 15, 2024: Hormone and Metabolic Research
https://read.qxmd.com/read/38621559/in-silico-design-of-a-novel-multi-epitope-vaccine-against-hcv-infection-through-immunoinformatics-approaches
#38
JOURNAL ARTICLE
Sajjad Ahmad, Fatemeh Mobini Demneh, Bushra Rehman, Taghreed N Almanaa, Nahid Akhtar, Hamidreza Pazoki-Toroudi, Ali Shojaeian, Mahdi Ghatrehsamani, Samira Sanami
Infection with the hepatitis C virus (HCV) is one of the causes of liver cancer, which is the world's sixth most prevalent and third most lethal cancer. The current treatments do not prevent reinfection; because they are expensive, their usage is limited to developed nations. Therefore, a prophylactic vaccine is essential to control this virus. Hence, in this study, an immunoinformatics method was applied to design a multi-epitope vaccine against HCV. The best B- and T-cell epitopes from conserved regions of the E2 protein of seven HCV genotypes were joined with the appropriate linkers to design a multi-epitope vaccine...
April 13, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38619666/peptide-based-vaccine-designing-against-endemic-causing-mammarenavirus-using-reverse-vaccinology-approach
#39
JOURNAL ARTICLE
Dwaipayan Chaudhuri, Joyeeta Datta, Satyabrata Majumder, Kalyan Giri
The rodent-borne Arenavirus in humans has led to the emergence of regional endemic situations and has deeply emerged into pandemic-causing viruses. Arenavirus have a bisegmented ambisense RNA that produces four proteins: glycoprotein, nucleocapsid, RdRp and Z protein. The peptide-based vaccine targets the glycoprotein of the virus encountered by the immune system. Screening of B-Cell and T-Cell epitopes was done based on their immunological properties like antigenicity, allergenicity, toxicity and anti-inflammatory properties were performed...
April 15, 2024: Archives of Microbiology
https://read.qxmd.com/read/38619272/virological-innate-and-adaptive-immune-profiles-shaped-by-variation-in-route-and-age-of-host-in-murine-cytomegalovirus-infection
#40
JOURNAL ARTICLE
Christopher P Coplen, Mladen Jergovic, Elana L Terner, Christine M Bradshaw, Jennifer L Uhrlaub, Janko Ž Nikolich
UNLABELLED: Human cytomegalovirus (hCMV) is a ubiquitous facultative pathogen, which establishes a characteristic latent and reactivating lifelong infection in immunocompetent hosts. Murine CMV (mCMV) infection is widely used as an experimental model of hCMV infection, employed to investigate the causal nature and extent of CMV's contribution to inflammatory, immunological, and health disturbances in humans. Therefore, mimicking natural human infection in mice would be advantageous to hCMV research...
April 15, 2024: Journal of Virology
keyword
keyword
42605
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.